I notice in the half yearly report they were still having turnaround delays between taking to lab and getting results back - (it's just endemic this prob)- so that might delay it.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025